This document provides details on a planned federal solicitation to distribute pre-exposure prophylaxis for HIV. The Health Resources and Services Administration intends to issue a solicitation for HIV PrEP Distribution-Pre-Exposure Prophylaxis Implementation and Dissemination to establish and administer a program for distributing donated PrEP medication to qualified uninsured patients. Key requirements of the program include establishing an eligibility verification process, issuing cards or vouchers for 30-day or 60-day supplies of donated PrEP drugs from Gilead at network pharmacies, and reimbursing or replenishing those pharmacies. The period of performance will be one base year and four option years. The solicitation is anticipated to be issued on or around December 1, 2019 as a full and open competition according to FAR Part 15 with NAICS code 541611 and size standard of $16.5 million.
